Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 20, 2004

View Archived Issues

Traditional Chinese medicine shows immunosuppressive effects on T- and B-cell activation

Chemokine receptor CXCR4 may not be involved in graft rejection

Alfacell licenses antibody from NIH

Approvable letter for Angeliq

Boston Biomedica sells diagnostics, biotech divisions to SeraCare Life Sciences

Three series of Src kinase inhibitors presented by AstraZeneca

Glenmark scientists identify novel PDE4 inhibitors

Aventis describes cyclic urea-based inhibitors of IGF-1R and other kinases

New COX-1 inhibitors under study at Fujisawa

New antitumor agents prepared and tested at Servier

Wyeth claims new agents for VZV and other herpes virus infections

Ivax patent covers new AMPA antagonists for stroke, epilepsy, etc.

GIP receptor antagonist improves glucose tolerance and insulin resistance in vivo

Identification of a novel serotonin transporter modulator

Involvement of neural histamine in energy homeostasis

Meta-analysis questions the long-term use of topical NSAIDs for the treatment of osteoarthritis

Roche and PDL to codevelop Zenapax for asthma

Aventis to transfer collaborative CRF-1 rights to Neurogen

Enzon and Pharmagene to develop PEGylated secretin for cystic fibrosis

Nexium completes European mutual recognition procedure for new indications

Panacea receives SBIR grant for Alzheimer's work

SPH-3047 set for phase III study for back pain

Samaritan licenses new Alzheimer's candidate from Georgetown University

Enrollment completed in ENDEAVOR III study

Tetrabenazine granted fast track and orphan drug designations

Lilly reviews significant second quarter events

Duloxetine recommended for approval in Europe

New HIV medication combining two NRTIs recommended for E.U. approval

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...